Pharma Mar SA 2021 SR
The report highlights Pharma Mar Group's 2021 performance in oncology, diagnostics, and RNA interference, emphasizing its commitment to marine-derived drug discovery. Key achievements include the approval of Zepzelca in multiple countries and the initiation of Phase III trials for plitidepsin against COVID-19. The company reported a workforce of 477 employees with 62% women and 45.3% women in management. Environmental efforts focused on energy efficiency and waste reduction, achieving a 100.5% increase in the use of returnable packaging. The report also details the group's alignment with several UN Sustainable Development Goals and its adherence to GRI standards.
Company: Pharma Mar SA
Sector: Manufacturing
Country: Spain
Year: 2021
Type: SR
Pages: 102
Back to company
Pharma Mar SA
Consolidated Non-Financial Information Statement
The report highlights Pharma Mar Group's 2021 performance in oncology, diagnostics, and RNA interference, emphasizing its commitment to marine-derived drug discovery. Key achievements include the approval of Zepzelca in multiple countries and the initiation of Phase III trials for plitidepsin against COVID-19. The company reported a workforce of 477 employees with 62% women and 45.3% women in management. Environmental efforts focused on energy efficiency and waste reduction, achieving a 100.5% increase in the use of returnable packaging. The report also details the group's alignment with several UN Sustainable Development Goals and its adherence to GRI standards.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Published
Feb 28, 2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Women on Board
Women in Management
Employees